👏 We’re thrilled to share that PACE Healthcare Capital portfolio company, Prenosis, has been granted #FDA approval for its breakthrough ImmunoScore™, a proprietary artificial intelligence software as a medical device (AI SaMD) for the detection and prediction of #sepsis. 👏
This signifies the FDA’s first-ever approval of an AI #diagnostic tool for sepsis, an elusive yet life-threatening condition responsible for up to 1 in 5 deaths worldwide. Sepsis, which occurs when a person has an overactive response to an infection, costs the U.S. #healthcare system billions of dollars and kills millions of people every year – more than all cancers combined.
PACE Healthcare Capital was the first institutional financial investor in Prenosis, and we could not be prouder to be part of its journey. It has been a privilege to support and witness the company's evolution.
We are thrilled to #celebrate this monumental milestone with the Prenosis team: first and foremost, Bobby Reddy, Jr., CEO and Founder; a terrific management team – Carlos Lopez-Espina, Angela McFarland, Robin Carver, RN, MSN, CIC and many more; and all who have meaningfully contributed along the way like Rashid Bashir, Sean Murphy, Edward Ogunro , Maria Siambekos, Kevin Klauer, and many others. Achieving FDA approval requires a Herculean effort, and this accomplishment speaks volumes about the dedication, hard work, and ingenuity of the entire Prenosis team.
But this is even better news for patients. Absent a cure, early detection and treatment – which Prenosis’ Sepsis ImmunoScore aims to better enable – is critical both to improve survivability and limit long-term damage to sepsis survivors.
Prenosis exemplifies the impactful #innovation PACE supports in #Chicago and the #Midwest, further demonstrating the region's importance in developing cutting-edge solutions. Prenosis’ success reinforces our commitment to nurturing the area's talent and innovation ecosystem. We are excited to continue supporting trailblazing companies who are making significant contributions to their industries and communities.
#Congratulations, again, to the team at Prenosis! Here's to continued success and the bright future of Midwest innovation!